Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Amt-151
Cancer
Multitude Therapeutics Inc.P1C (36)
AN4005
Cancer
Adlai Nortye Biopharma Co., Ltd.P1C (36)
Anti-Cd70-Car-T Cells
Advanced Solid Tumor
Zhejiang UniversityP1C (36)
APG 2449
Cancer
Ascentage Pharma Group Inc.P1C (36)
Apr-1051
Cancer
Aprea TherapeuticsP1C (36)
arc101
Cancer
Third Arc BioP1C (36)
ask120067
Cancer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.P1C (36)
Askc202
Cancer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.P1C (36)
Ati-2231
Cancer
Washington University School of MedicineP1C (36)
Axt-1003
Cancer
Axter Therapeutics (Beijing) Co., LtdP1C (36)
b4t2-001 autologous car-t
Cancer
Shanghai East HospitalP1C (36)
b4t2-001 autologous car t cells
Cancer
Shanghai East HospitalP1C (36)
ba1202
Cancer
Shandong Boan Biotechnology Co., LtdP1C (36)
bal0891
Cancer
SillaJen, Inc.P1C (36)
bat6021
Cancer
Bio-Thera SolutionsP1C (36)
bb102
Cancer
Broadenbio Ltd., Co.P1C (36)
bb3008
Cancer
Broadenbio Ltd., Co.P1C (36)
bg-68501
Cancer
BeiGeneP1C (36)
bg-75098
Cancer
BeOne MedicinesP1C (36)
bg-75202
Cancer
BeOne MedicinesP1C (36)
bg-89894
Cancer
BeOne MedicinesP1C (36)
Bgb-26808
Cancer
BeOne MedicinesP1C (36)
Bgb-58067
Cancer
BeOne MedicinesP1C (36)
Bgb-A3055
Cancer
BeiGeneP1C (36)
Bgb-B455
Cancer
BeOne MedicinesP1C (36)
Showing 276 to 300 of 534 assets
PreviousPage 12 of 22Next